mycosis fungoides
Showing 1 - 25 of 58
T-cell Lymphoma, NK-Cell Lymphoma, T-cell Prolymphocytic Leukemia Trial in United States (Optional Blood Sample, Optional Nail
Recruiting
- T-cell Lymphoma
- +30 more
- Optional Blood Sample
- Optional Nail Sample
-
Duarte, California
- +25 more
Jul 28, 2023
Mycosis Fungoides, Sezary Syndrome, Mycosis Fungoides/Sezary Syndrome Trial in Saint Louis (Tulmimetostat)
Not yet recruiting
- Mycosis Fungoides
- +2 more
-
Saint Louis, MissouriWashington University School of Medicine
Jul 13, 2023
Mycosis Fungoides Trial in Istanbul (biopsy)
Recruiting
- Mycosis Fungoides
- biopsy
-
Istanbul, TurkeyBezmialem Vakif University Hospital
Jun 6, 2023
CTCL, Mycosis Fungoides, Sezary Syndrome Trial in New York (Ritlecitinib)
Recruiting
- CTCL
- +2 more
-
New York, New YorkIcahn School of Medicine at Mount Sinai
May 18, 2023
Cutaneous T Cell Lymphoma, Mycosis Fungoides Trial (Hypericin, Visible Light)
Not yet recruiting
- Cutaneous T Cell Lymphoma
- Mycosis Fungoides
- Hypericin
- Visible Light
- (no location specified)
May 23, 2023
Interleukin (IL) -35 in Mycosis Fungoides:Case Control Study
Recruiting
- Mycosis Fungoides
- Skin biopsy
-
Giza, EgyptCairo University
May 3, 2023
Mycosis Fungoides Trial (Imiquimod, Radiation Therapy)
Not yet recruiting
- Mycosis Fungoides
- Imiquimod
- Radiation Therapy
- (no location specified)
Apr 29, 2023
Peripheral T Cell Lymphoma (PTCL), Cell Therapy Trial in United States (MT-101, MT-101 + Conditioning (Lymphodepleting)
Recruiting
- Lymphoma, T-Cell, Peripheral
- +4 more
- MT-101
- MT-101 + Conditioning (Lymphodepleting) Chemotherapy
-
Duarte, California
- +8 more
Jan 27, 2023
Cutaneous T Cell Lymphoma, Mycosis Fungoides Trial in New York (UVADEX® (methoxsalen) Sterile Solution in conjunction with the
Recruiting
- Cutaneous T Cell Lymphoma
- Mycosis Fungoides
- UVADEX® (methoxsalen) Sterile Solution in conjunction with the UVAR® THERAKOS® CELLEX Photopheresis
- THERAKOS® CELLEX photopheresis system
-
New York, New YorkHerbert Irving Pavilion
Dec 23, 2022
Mycosis Fungoides, Recurrent Mycosis Fungoides, Recurrent Mycosis Fungoides and Sezary Syndrome Trial in United States
Recruiting
- Mycosis Fungoides
- +11 more
- Biospecimen Collection
- +5 more
-
Duarte, California
- +12 more
Jan 7, 2023
Adult T-Cell Lymphoma/Leukemia, Sezary Syndrome, Mycosis Fungoides Trial run by the NCI (Recombinant human Interleukin-15
Completed
- Adult T-Cell Lymphoma/Leukemia
- +2 more
- Recombinant human Interleukin-15 (rhIL-15)
- Mogamulizumab
-
Bethesda, MarylandNational Institutes of Health Clinical Center
Dec 9, 2022
Mycosis Fungoides, Sezary Syndrome, Lymphoma, T-Cell, Cutaneous Trial in Worldwide (resminostat, Placebo)
Active, not recruiting
- Mycosis Fungoides
- +2 more
- resminostat
- Placebo
-
Graz, Austria
- +53 more
Dec 12, 2022
Cutaneous T Cell Lymphoma, Mycosis Fungoides Trial (Mogamulizumab, Brentuximab vedotin)
Not yet recruiting
- Cutaneous T Cell Lymphoma
- Mycosis Fungoides
- Mogamulizumab
- Brentuximab vedotin
- (no location specified)
Dec 7, 2022
Response to Gemcitabine Chemotherapy in Mycosis Fungoides
Recruiting
- Lymphoma, T-Cell, Cutaneous
- Mycosis Fungoides
- single-arm, non-randomized Biodynamic imaging (BDI)
-
Indianapolis, IndianaIndiana University School of Medicine, Department of Dermatology
Nov 16, 2022
Mycosis Fungoides, Lymphomatoid Papulosis, Sezary Syndrome Trial in United States (brentuximab vedotin)
Recruiting
- Mycosis Fungoides
- +2 more
- brentuximab vedotin
-
Stanford, California
- +7 more
Nov 3, 2022
Mycosis Fungoides, Lymphoma, T-Cell, Cutaneous, Sézary Syndrome Trial in United States (Naloxone Hydrochloride Lotion, 0.5%,
Terminated
- Mycosis Fungoides
- +2 more
- Naloxone Hydrochloride Lotion, 0.5%
- Placebo Lotion
-
Little Rock, Arkansas
- +15 more
Oct 26, 2022
T-cell Lymphoma, Cutaneous/Peripheral T-Cell Lymphoma, Peripheral T-cell Lymphoma Trial in Chicago (Fenretinide)
Not yet recruiting
- T-cell Lymphoma
- +10 more
-
Chicago, IllinoisRush University Medical Center
Oct 24, 2022
Sezary Syndrome, Mycosis Fungoides Trial in Stanford (Mogamulizumab, LD TSEBT)
Recruiting
- Sezary Syndrome
- Mycosis Fungoides
- Mogamulizumab
- LD TSEBT
-
Stanford, CaliforniaStanford Cancer Center
Oct 19, 2022
Mycosis Fungoides Trial in Houston (Brentuximab vedotin)
Recruiting
- Mycosis Fungoides
- Brentuximab vedotin
-
Houston, TexasMD Anderson Cancer Center
Oct 14, 2022
Mycosis Fungoides Trial in Edmonton (Cemiplimab)
Not yet recruiting
- Mycosis Fungoides
-
Edmonton, Alberta, CanadaCross Cancer Institute
Sep 12, 2022
ID Of Prognostic Factors In Mycosis Fungoides/Sezary Syndrome
Recruiting
- Mycosis Fungoides
- Non-Hodgkin's Lymphoma
-
Duarte, California
- +12 more
Jun 17, 2022
Mycosis Fungoides, Primary Cutaneous T-Cell Non-Hodgkin Lymphoma, Sezary Syndrome Trial in Atlanta (procedure, biological,
Recruiting
- Mycosis Fungoides
- +2 more
- Extracorporeal Photopheresis
- +2 more
-
Atlanta, GeorgiaEmory University Hospital
Jun 15, 2022
Localized Skin Lesion, Mycosis Fungoides Trial in Houston (Quality-of-Life Assessment, Questionnaire Administration, Radiation
Recruiting
- Localized Skin Lesion
- Mycosis Fungoides
- Quality-of-Life Assessment
- +2 more
-
Houston, TexasM D Anderson Cancer Center
May 13, 2022
Mycosis Fungoides Trial in Leiden (Chlormethine)
Recruiting
- Mycosis Fungoides
-
Leiden, NetherlandsCentre for Human Drug Research
Mar 29, 2022
Mycosis Fungoides, Sezary Syndrome, Stage IB Mycosis Fungoides and Sezary Syndrome AJCC v8 Trial in Jacksonville (Pembrolizumab)
Recruiting
- Mycosis Fungoides
- +12 more
- Pembrolizumab
-
Jacksonville, FloridaMayo Clinic in Florida
Mar 22, 2022